DOI: 10.1055/s-00000054

Pharmacopsychiatry

Issue 06 · Volume 41 · November 2008 DOI: 10.1055/s-002-14172

Review

221
Glassman, A.: Depression and Cardiovascular Disease

Original Paper

Original Paper

226
Ehrlich, S.; Franke, L.; Schott, R.; Salbach-Andrae, H.; Pfeiffer, E.; Lehmkuhl, U.; Uebelhack, R.: Platelet Monoamine Oxidase Activity in Underweight and Weight-Recovered Females with Anorexia Nervosa
232
Häßler, F.; Glaser, T.; Pap, A. F.; Beneke, M.; Diefenbacher, A.; Reis, O.: A Double-blind Placebo-controlled Discontinuation Study of Zuclopenthixol for the Treatment of Aggressive Disruptive Behaviours in Adults with Mental Retardation – Secondary Parameter Analyses
240
Arbaizar, B.; Gómez-Acebo, I.; Llorca, J.: Quality of Reporting Controlled Clinical Trials on Treatment of the Acute Mania Phase of Bipolar Disorder with New Antipsychotic Drugs
242
Du, Y.; Scheidt-Nave, C.; Knopf, H.: Use of Psychotropic Drugs and Alcohol among Non-Institutionalised Elderly Adults in Germany
252
Adli, M.; Pilhatsch, M.; Bauer, M.; Köberle, U.; Ricken, R.; Janssen, G.; Ulrich, S.; Bschor, T.: Safety of High-intensity Treatment with the Irreversible Monoamine Oxidase Inhibitor Tranylcypromine in Patients with Treatment-resistant Depression

Letter

258
Schulz-Du Bois, C.; Schulz-Du Bois, A. C.; Bewig, B.; Gerstner, I.; Aldenhoff, J. B.; Cascorbi, I.; Ufer, M.: Major Increase of Quetiapine Steady-State Plasma Concentration Following Co-Administration of Clarithromycin: Confirmation of the Pharmacokinetic Interaction Potential of Quetiapine
259
Schlotterbeck, P. M.; Vehren, T.; Milenovic, S.; Hiemke, C.; Kircher, T.; Leube, D.: No Influence of Dialysis on Mirtazapine – A Case Report